Psoriatic Arthritis vs. Gout: Understanding the Distinctions

Psoriatic arthritis (PsA) and gout are both forms of inflammatory arthritis, conditions that can lead to significant pain and swelling in the body's joints, particularly those in the fingers, toes, knees, and ankles. Despite sharing these common symptoms, they originate from distinctly different processes and therefore require unique approaches to management and treatment. Understanding these fundamental differences is crucial for accurate diagnosis and effective long-term care. This comprehensive guide will delve into the specific symptoms, underlying causes, diagnostic procedures, and treatment strategies for both PsA and gout, also exploring the fascinating connection between psoriatic disease and an increased risk of gout.

Verywell / Jessica Olah

Symptoms: Distinguishing Features

While both psoriatic arthritis and gout manifest with joint pain and inflammation, their specific symptomatic presentations often differ, providing important clues for diagnosis. Recognizing these subtle yet significant variations is essential for healthcare providers to accurately identify the underlying condition. Both diseases can lead to considerable discomfort, but the pattern, duration, and associated signs can vary widely between the two.

Psoriatic Arthritis Symptoms

Psoriatic arthritis affects less than 1% of the American population, yet a significant proportion of those affected also experience the inflammatory skin condition psoriasis. Psoriasis itself is characterized by an accelerated turnover of skin cells, leading to the formation of red patches covered in silvery scales. Alarmingly, nearly one-third of individuals living with psoriasis will eventually develop PsA, underscoring the importance of vigilance for joint symptoms in this patient group. Prompt evaluation by a healthcare provider is recommended if joint pain emerges in a person with psoriasis.

A hallmark of PsA is the experience of pain and stiffness in multiple joints, which can affect either one side of the body or both. Large joints, particularly in the lower extremities such as the knees and ankles, are frequently involved, though PsA has the potential to impact any joint. A distinctive feature of PsA often involves the nails, presenting as pitting, crumbling, ridging, and separation of the nail from the nailbed. These nail changes can often precede or accompany the joint symptoms, serving as an important diagnostic indicator for clinicians.

Beyond the joints, PsA can manifest with specific inflammatory patterns. Enthesitis, an inflammation of the entheses—the sites where tendons and ligaments attach to bone—is a common and often painful symptom. This typically affects areas like the backs of the heels and the soles of the feet, causing localized tenderness. Another striking feature is dactylitis, characterized by extreme swelling of entire fingers or toes, often referred to as "sausage digits" due to their uniform, swollen appearance. Furthermore, some individuals with PsA may experience spine involvement, known as psoriatic spondylitis, leading to stiffness and pain in the back or neck and difficulty with bending. Eye inflammation, such as uveitis, can also occur, causing symptoms like redness, pain, blurred vision, and light sensitivity.

Gout Symptoms

Gout is distinguished by its characteristic pattern of intermittent, sudden, and intensely painful episodes, commonly known as gout attacks. During an attack, affected joints become red, hot, and swollen. These attacks frequently strike in the middle of the night, often waking individuals abruptly due to excruciating pain. While a gout attack can last anywhere from seven to 14 days, individuals typically experience symptom-free periods between flares. The acute nature and specific presentation of these attacks are key diagnostic features.

The most common initial symptom of gout is severe pain in the big toe, specifically at the first metatarsophalangeal joint, a condition sometimes referred to as podagra. The pain can be so excruciating that even the slightest touch, like that of bedding, becomes intolerable. The affected big toe also exhibits warmth and redness. While the big toe is the most frequent site, gout can affect any joint, and it's possible for more than one joint to be involved simultaneously, a condition known as polyarticular gout. Other common sites for gout attacks include the feet, ankles, knees, wrists, thumbs, and elbows. Notably, polyarticular attacks are observed in 15%–40% of gout patients, particularly women.

A long-term complication of chronic gout is the formation of tophi. These are noticeable lumps that develop beneath the skin and around the joints, consisting of crystallized uric acid deposits. Tophi are typically seen in individuals with severe or chronic gout and can contribute to bone and cartilage destruction due to ongoing inflammation. Even after the most intense phase of a gout attack subsides (typically 12–24 hours after onset), some joint discomfort can linger for days or even weeks. For those with severe or chronic gout, attacks may persist longer and affect a greater number of joints. Beyond pain, warmth and redness are consistent findings in affected joints, and as a gout attack progresses, individuals may experience a limited range of motion in the involved joints. While rare, gout can also affect the spine, particularly the lumbar spine in the lower back, and can involve the sacroiliac joints, which connect the sacrum at the base of the spine to the hip bone.

PsA–Gout Connection: An Increased Risk

A significant clinical observation highlights that individuals with psoriatic disease—encompassing both psoriasis and psoriatic arthritis—face an elevated risk of developing gout. This association has been recognized for decades and is believed to stem from the body's metabolism of uric acid. Uric acid is a natural byproduct formed when the body breaks down purines, substances found in human cells and numerous foods. In the context of psoriatic disease, elevated uric acid levels may contribute to both the overproduction of skin cells seen in psoriasis and systemic inflammation. For individuals with gout, this same uric acid accumulates and crystallizes within and around the joints, triggering painful attacks.

Research has provided compelling evidence for this connection. A 2014 study published in the journal Drug Development Research investigated uric acid blood levels in 338 participants with psoriasis. The findings revealed that 20% of these individuals had elevated uric acid levels, and psoriasis itself was identified as a stronger predictor of hyperuricemia (high uric acid levels). Further reinforcing this link, a large-scale study from 2015 sought to definitively determine if people with psoriasis and PsA indeed have a higher risk of gout. This extensive study, which tracked 98,810 individuals in the United States with psoriasis and/or PsA over many years, yielded significant results.

The 2015 study demonstrated that the risk of developing gout was almost twice as high for individuals with psoriasis compared to those without the condition. More strikingly, people diagnosed with both psoriasis and psoriatic arthritis had a risk five times greater than the general population. The researchers emphasized the groundbreaking nature of these findings, noting that while a link had long been suspected, this was the first large-scale study to quantify the risk of gout in individuals with psoriatic disease. These compelling results underscore the critical importance for healthcare professionals to be vigilant for gout as a potential complication in patients presenting with psoriatic disease, even when other inflammatory joint conditions are already present.

Causes: Differentiating Origins

The fundamental causes of psoriatic arthritis and gout are distinct, reflecting their differing classifications as an autoimmune disease and a metabolic disorder, respectively. Understanding these underlying mechanisms is crucial for appropriate diagnosis and targeted therapeutic interventions. While both conditions involve inflammation, the pathways leading to that inflammation are unique.

Psoriatic Arthritis Causes

Psoriatic arthritis is classified as an autoimmune disease, meaning it arises from a malfunction in the body's immune system. Instead of solely defending against foreign invaders like viruses and bacteria, the immune system mistakenly turns its attack on healthy tissues, most commonly the joints, and in many cases, the skin. While the exact trigger for this autoimmune response in PsA remains unknown, researchers have identified several contributing factors that appear to influence its development.

Genetic predisposition plays a significant role in PsA. A key area of study revolves around a family of genes known as the human leukocyte antigen (HLA) complex. HLA genes are vital for the immune system's ability to differentiate the body's own proteins from those of foreign pathogens. Variations or specific alleles within the HLA genes are strongly linked to the development of PsA, and they can also influence the severity, specific type, and overall progression of the disease. Beyond specific genes, a family history of psoriatic disease (either psoriasis or PsA) significantly increases an individual's risk, with approximately 40% of PsA patients having at least one close relative with the condition, indicating a strong familial component despite an unknown inheritance pattern.

In addition to genetic factors, environmental triggers are believed to play a role in initiating or exacerbating PsA, particularly in genetically susceptible individuals. Physical injuries, various infections, chronic psychological stress, and exposure to certain environmental toxins have all been implicated as potential triggers for the onset of psoriatic arthritis. Several risk factors for PsA have been identified, including a family history of the disease, which elevates risk. The most significant risk factor is having psoriasis, as it substantially increases the likelihood of developing PsA. While PsA can affect individuals of any age, it most commonly manifests in adults between 35 and 55 years old. Furthermore, smoking is a known risk factor for PsA. The connection is not necessarily direct, but rather attributed to the widespread chronic inflammation that smoking is known to promote throughout the body, making individuals more susceptible to autoimmune conditions.

Gout Causes

Historically, gout was often referred to as the "rich man's disease" or the "disease of kings," erroneously associating it exclusively with affluent men who indulged in rich diets and excessive drinking. Modern medical understanding has corrected this misconception, recognizing gout primarily as a metabolic disorder driven by elevated levels of uric acid in the blood and tissues, rather than socioeconomic status. This accumulation of uric acid eventually precipitates the characteristic joint pain and swelling.

Genetics are a significant component in an individual's susceptibility to gout. Numerous studies have identified dozens of genes that contribute to the condition's development. Among the most influential are SLC2A9 and ABCG2, which exert the strongest impact on uric acid levels. The SLC2A9 gene is primarily responsible for producing a protein found in the kidneys that regulates the body's urate levels (urate being the salt derived from uric acid). Genetic variations in SLC2A9 can lead to increased reabsorption of urate back into the bloodstream while simultaneously decreasing its excretion through urine, thereby elevating blood uric acid. Conversely, the ABCG2 gene provides instructions for a protein critical in releasing urate from the body. Mutations or changes in ABCG2 can impair this protein's ability to excrete urate into the gut, also resulting in higher blood uric acid concentrations.

Beyond genetic predispositions, several non-genetic factors and lifestyle choices can significantly influence the development of gout and trigger acute attacks. These factors contribute to elevated urate levels in the body. A major contributor is the consumption of foods and beverages that are rich in purines, which are metabolized into uric acid. Common high-purine sources include seafood, red meat, alcohol (especially beer and spirits), and sugary beverages, particularly those sweetened with high-fructose corn syrup. Other notable risk factors for gout include being male, as men are three times more likely to develop gout than women, largely because they typically maintain higher uric acid levels throughout much of their lives and produce less estrogen, a hormone that aids in urate excretion. Age also plays a role, with risk increasing over time; in women, the risk rises after menopause due to declining estrogen levels. Obesity, defined as a body mass index (BMI) of 30 or greater, significantly increases risk, as does metabolic syndrome—a cluster of conditions including high blood pressure, high blood sugar, excessive waist fat, and abnormal cholesterol or triglyceride levels. Decreased kidney function, congestive heart failure, and the excessive use of certain diuretics (water pills) are also associated with an increased risk of gout.

Diagnosis: Pinpointing the Condition

Accurately diagnosing psoriatic arthritis or gout is a multi-faceted process, as there is no single definitive test for either condition. While elevated blood uric acid levels can be indicative of gout, this finding alone cannot definitively rule out PsA, as individuals with psoriatic disease can also have high uric acid levels without having gout. Therefore, healthcare providers employ a combination of clinical assessments, laboratory tests, and imaging studies to differentiate between these conditions and exclude other similar diseases.

Psoriatic Arthritis Diagnosis

An early and precise diagnosis of psoriatic arthritis is crucial to prevent irreversible joint damage and deformity. The diagnostic process typically involves a thorough review of symptoms, a detailed medical and family history, a comprehensive physical examination, specific laboratory tests, and various imaging studies. Your doctor will inquire about the nature of your symptoms, including their onset, duration, and any potential triggers, paying close attention to skin and nail manifestations, which are highly indicative of PsA.

Sharing any personal history of psoriasis or family history of psoriatic disease (psoriasis or PsA) is vital information for your healthcare provider. During the physical examination, the doctor will meticulously assess your joints and tendons for signs of swelling, tenderness, and range of motion limitations, along with inspecting your fingernails for characteristic changes like pitting or separation. Blood work plays a supportive role in diagnosis; while an erythrocyte sedimentation rate (ESR) can indicate general inflammation, it is not specific to PsA. Crucially, tests for rheumatoid factor (RF) and anti-CCP antibody are performed to help rule out rheumatoid arthritis (RA), as these markers are typically elevated in RA but not in PsA. In cases of suspected spinal involvement, HLA-B27 testing may be conducted, as this genetic marker is often associated with psoriatic spondylitis.

Imaging studies provide critical visual evidence of joint and bone changes. X-rays, magnetic resonance imaging (MRI), and ultrasound scans can reveal bone erosions or joint damage. In PsA, doctors specifically look for these changes in the hands, feet, and spine, as joint damage can occur relatively early in the disease course in these areas. To definitively differentiate from gout, a joint aspiration is often performed. This procedure involves using a needle to extract a sample of fluid from an affected joint. The fluid is then examined under a microscope for the presence of uric acid crystals; if these crystals are found, it strongly points towards a diagnosis of gout.

Gout Diagnosis

The diagnosis of gout typically relies on a combination of clinical symptoms and the characteristic appearance of affected joints during an acute attack. To confirm the diagnosis and rule out other potential causes of joint symptoms, your doctor may also order specific tests. The most accurate and definitive test for diagnosing gout is a joint fluid test, also known as a joint aspiration. During this procedure, a sample of fluid is drawn from the affected joint using a needle. When this joint fluid is examined under a microscope, the presence of urate crystals is a hallmark diagnostic finding for gout.

Blood tests are also commonly requested to measure uric acid levels in the blood. However, it's important to note that uric acid levels can sometimes be misleading in diagnosing gout. Many individuals may have elevated uric acid levels (hyperuricemia) without ever developing gout symptoms, while conversely, some individuals experiencing typical gout symptoms may have uric acid levels within the normal range during an acute attack. Therefore, a high uric acid level supports a diagnosis but is not definitive on its own. Imaging studies, such as X-rays of the affected joints, can be helpful in ruling out other conditions that might be causing joint pain. Additionally, ultrasound imaging has proven valuable in detecting urate crystal deposits within joints and identifying tophi lumps, even before they become visibly apparent.

Treatment: Managing Symptoms and Preventing Progression

While there is currently no cure for either psoriatic arthritis or gout, effective treatments are available for both conditions. The primary goals of treatment are to alleviate pain, reduce inflammation and other symptoms, and prevent long-term joint damage and complications. The therapeutic approaches, however, differ significantly based on the underlying pathology of each disease.

Psoriatic Arthritis Treatment

Treatment for psoriatic arthritis is highly individualized, depending on the severity of the condition, the specific type of PsA, and whether joint damage has already occurred. For individuals with mild disease who have not yet experienced joint damage, nonsteroidal anti-inflammatory drugs (NSAIDs) are often the first line of treatment. Common examples include Advil or Motrin (ibuprofen) and Aleve (naproxen), which help reduce pain and inflammation.

For patients with more active disease, characterized by frequent pain, swelling, and significant skin symptoms, conventional disease-modifying antirheumatic drugs (DMARDs) are typically prescribed as second-line therapies. Medications such as Trexall (methotrexate) work by modulating the immune system to prevent progressive damage to the joints, spine, and tendons. In cases where joint damage has already occurred or symptoms are not adequately controlled by conventional DMARDs, biologics represent a highly effective class of treatment. These advanced therapies specifically target components of the immune system involved in inflammation, significantly slowing disease progression and improving symptoms. The newest treatment options for PsA include Janus kinase (JAK) inhibitors. These oral medications function by dampening specific pathways within the immune system, thereby reducing joint pain, swelling, and preventing further joint damage.

In addition to pharmacological interventions, several adjunctive therapies can help manage PsA symptoms and improve quality of life. Physical therapy is often recommended to help individuals regain or maintain their range of motion, reduce pain, strengthen supportive muscles, and stabilize the spine, especially when psoriatic spondylitis is present. For managing the associated skin symptoms of psoriasis, topical treatments applied directly to the skin and phototherapy (light therapy) are effective options. A comprehensive treatment plan often integrates these various approaches to address both the joint and skin manifestations of psoriatic arthritis.

Gout Treatment

Gout treatment primarily focuses on two key objectives: rapidly reducing the pain and inflammation associated with acute gout attacks, and preventing future attacks and complications by lowering uric acid levels in the blood. Different classes of medications are used to achieve these goals. For acute gout attacks, nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to quickly reduce pain and swelling. Mitigare (colchicine) is another effective medication for acute attacks; it works by reducing inflammation and pain, particularly if taken within 24 hours of symptom onset. Corticosteroids, such as prednisone, are also powerful anti-inflammatory agents that can provide rapid relief from pain and swelling during a gout flare, often used when NSAIDs or colchicine are contraindicated or ineffective.

To prevent recurrent gout attacks and mitigate long-term complications like tophi formation and joint damage, medications aimed at lowering uric acid levels are crucial. These include allopurinol (Aloprin) and febuxostat (Uloric), both taken orally, which work by reducing the body's production of uric acid. Probenecid (Benemid), also an oral medication, helps the kidneys excrete more uric acid. For severe, chronic gout that doesn't respond to other therapies, Krustexxa (pegloticase) is an intravenous infusion that breaks down uric acid, effectively lowering its levels.

While medication forms the cornerstone of gout treatment, dietary modifications play a significant supporting role in managing symptoms and preventing attacks. Individuals with gout are advised to make specific dietary choices. This includes choosing healthy beverages by limiting or avoiding alcohol, especially beer and spirits, and beverages sweetened with high-fructose corn syrup, as these can significantly elevate uric acid. Equally important is avoiding foods high in purines, which the body converts into uric acid. Common culprits include red meats, organ meats (such as liver), and certain purine-rich seafood like anchovies and sardines. Adhering to these dietary guidelines, in conjunction with prescribed medications, is essential for effective long-term gout management.

Prevention: A Focus on Management

Inflammatory arthritis conditions like psoriatic arthritis and gout are generally not entirely preventable. While researchers have identified specific risk factors that increase an individual's susceptibility to these conditions, there are currently no treatments or definitive preventive measures that can guarantee someone will not develop PsA or gout. However, once diagnosed, the focus shifts from prevention of onset to prevention of flare-ups and disease progression.

Given that some individuals may experience both psoriatic arthritis and gout, it becomes especially important for those diagnosed with PsA to be vigilant for any signs or symptoms suggestive of gout. While the underlying causes are distinct, the interconnectedness, particularly through uric acid metabolism, means that one condition can influence the other. Although the conditions themselves may not be preventable, the severity and frequency of PsA flare-ups and gout attacks are often manageable. The best strategies for preventing symptom flares and protecting joint health in both conditions involve a combination of stress management techniques, maintaining a healthy and appropriate diet, engaging in regular physical activity, and, critically, diligently adhering to the prescribed treatment plan. Proactive management empowers individuals to maintain a better quality of life and minimize the impact of these chronic inflammatory conditions.

Summary

Psoriatic arthritis and gout are two distinct types of inflammatory arthritis, sometimes confused due to shared symptoms such as pain and swelling in the fingers and toes. However, their fundamental origins and mechanisms differ significantly. Psoriatic arthritis is an autoimmune condition where the immune system mistakenly attacks healthy joints, often linked to the skin condition psoriasis. In contrast, gout is a metabolic disorder resulting from an excessive buildup of uric acid in the blood, leading to crystal deposits in the joints. Distinct diagnostic methods, including specific blood work and joint fluid aspiration, are employed to differentiate between these conditions. While complete prevention of either condition is rarely possible, both psoriatic arthritis and gout are manageable and treatable through various medical interventions and lifestyle adjustments.

A Word From Verywell

If you are experiencing persistent joint pain or stiffness, consulting a rheumatologist is highly recommended. A rheumatologist is a medical specialist focused on arthritis, other musculoskeletal conditions, and systemic autoimmune diseases. While many types of arthritis may present with overlapping symptoms, they represent different diagnoses with unique implications for your health. Therefore, each form of arthritis requires a distinct evaluation and tailored treatment approach to ensure optimal outcomes. If you receive a diagnosis of psoriatic arthritis or gout, it is paramount to commit to managing these conditions effectively. Early and aggressive treatment strategies are key to reducing the potential for irreversible joint damage, alleviating symptoms, and significantly improving your overall quality of life.

14 Sources

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.

1. Ogdie A, Weiss P. The epidemiology of psoriatic arthritis. Rheum Dis Clin North Am. 2015;41(4):545-568. doi:10.1016/j.rdc.2015.07.001
2. National Psoriasis Foundation. Psoriasis statistics. Updated October 8, 2020.
3. Johns Hopkins Arthritis Center. Symptoms and diagnosis of gout
4. Avhad G, Ghuge P. Podagra. Indian Dermatol Online J. 2014;5(Suppl 2):S134-S135. doi:10.4103/2229-5178.146196
5. Fargetti S, Goldenstein-Schainberg C, Silva Abreu A, Fuller R. Refractory gout attack. Case Rep Med. 2012;2012:657694. doi:10.1155/2012/657694
6. Cardoso FN, Omoumi P, Wieers G, et al. Spinal and sacroiliac gouty arthritis: report of a case and review of the literature. Acta Radiol Short Rep. 2014;3(8):2047981614549269. doi:10.1177/2047981614549269
7. Gisondi P, Targher G, Cagalli A, Girolomoni G. Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2014 Jan;70(1):127-30. doi:10.1016/j.jaad.2013.09.005
8. Merola JF, Wu S, Han J, Choi HK, Qureshi AA. Psoriasis, psoriatic arthritis and risk of gout in US men and women. Ann Rheum Dis. 2015;74(8):1495-1500. doi:10.1136/annrheumdis-2014-205212
9. MedlinePlus. Psoriatic arthritis. Updated August 18, 2020.
10. Ogdie A, Gelfand JM. Clinical risk factors for the development of psoriatic arthritis among patients with psoriasis: a review of available evidence. Curr Rheumatol Rep. 2015;17(10):64. doi:10.1007/s11926-015-0540-1
11. Cleveland Clinic. Psoriatic arthritis. Updated November 29, 2019.
12. MedlinePlus. Gout. Updated September 29, 2020.
13. Cleveland Clinic. Gout. Updated November 15, 2020.
14. Belasco J, Wei N. Psoriatic arthritis: What is happening at the joint?. Rheumatol Ther. 2019;6(3):305-315. doi:10.1007/s40744-019-0159-1